合成路线1
该中间体在本合成路线中的序号:
(IV) The benzoylation of 1,3,5(10)-estratrien-3,17beta-diol (I) with benzoyl chloride (II) by means of NaOH in THF-water gives 3-benzoyloxy-1,3,5(10)-estratrien-17beta-ol (III), which is acylated with bromoacetyl bromide (IV) by means of pyridine in THF-CCl4 yielding 3-benzoyloxy-17beta-bromoacetoxy 1,3,5(10)-estratriene (V). Finally, this compound is condensed with silver 4-[4-[bis(2-chloroethyl)amino]phenyl]butyrate (VI) in DMSO.
【1】
Asano, K.; Tamura, H.; Tanaka, H.; Enomoto, S.; Novel estradiol compound, its preparation and anti-tumor agent containing the same. BE 0878186; JP 55027121 .
|
【2】
Castaner, J.; Serradell, M.N.; KM-2210. Drugs Fut 1984, 9, 5, 334.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
34210 |
(8R,9S,13S,14S,17S)-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
|
50-28-2 |
C18H24O2 |
详情 | 详情
|
(II) |
10643 |
(1S,2S,3R,4S,7S,8S,10R,13S)-10-(acetoxy)-1,7-bis(benzyloxy)-13-[[tert-butyl(dimethyl)silyl]oxy]-8,12,15,15-tetramethyl-5,9-dioxo-4-[(phenylsulfanyl)methyl]tricyclo[9.3.1.0(3,8)]pentadec-11-en-2-yl benzoate
|
|
C55H66O9SSi |
详情 |
详情
|
(III) |
34211 |
(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-yl benzoate
|
|
C25H28O3 |
详情 |
详情
|
(IV) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(V) |
34212 |
(8R,9S,13S,14S,17S)-17-[(2-bromoacetyl)oxy]-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-yl benzoate
|
|
C27H29BrO4 |
详情 |
详情
|
(VI) |
34213 |
silver(1+) 4-[4-[bis(2-chloroethyl)amino]phenyl]butanoate
|
|
C14H18AgCl2NO2 |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(A) The methylation of 2-amino-5-chlorobenzophenone (I) with dimethyl-sulfate affords the 5-chloro-2-methylaminobenzophenone (II), which is conden-sed with bromoacetyl bromide (A) to yieId 2-(2-bromo-N-methylacetamido)-5-chlorobenzophenone (III). The amonolysis of (III) with ammonia in methanol gives 2-(2-amino-N-methylacetamido)-5-chlorobenzophenone (IV), which is finally condensed with diketene (B) in refluxing acetone. This product can also be obtained by condensation of 7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one (V) with acetyl chloride (C) and triethylamine in ether or with diketene (B) in acetone.
【1】
Szmuszkovicz, J.; et al.; Tetrahedron Lett 1971, 39, 39, 3665.
|
【2】
Szmuszkovicz, J.; Oxazinobenzodiazepine derivatives. DE 1947226; ES 371392; FR 2018432; GB 1222294 .
|
【3】
Szmuszkovicz, J.; Process for the preparation of 11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-4H-[1,3]oxazino[3,2-d]benzodiazepine-4,7-6H-dione. CH 530414; JP 49025953B; NL 7014824; US 3575965 .
|
【4】
Castaner, J.; Chatterjee, S.S.; Ketazolam. Drugs Fut 1976, 1, 6, 293.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
11367 |
4-Methylene-2-oxetanone; Acetyl ketene
|
674-82-8 |
C4H4O2 |
详情 | 详情
|
(A) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(I) |
10279 |
(2-Amino-5-chlorophenyl)(phenyl)methanone; 2-Amino-5-chlorobenzophenone
|
719-59-5 |
C13H10ClNO |
详情 | 详情
|
(II) |
33972 |
[5-chloro-2-(methylamino)phenyl](phenyl)methanone
|
1022-13-5 |
C14H12ClNO |
详情 | 详情
|
(III) |
33973 |
N-(2-benzoyl-4-chlorophenyl)-2-bromo-N-methylacetamide
|
|
C16H13BrClNO2 |
详情 |
详情
|
(IV) |
33974 |
2-amino-N-(2-benzoyl-4-chlorophenyl)-N-methylacetamide
|
|
C16H15ClN2O2 |
详情 |
详情
|
(V) |
33975 |
7-chloro-1-methyl-5-phenyl-1,3,4,5-tetrahydro-2H-1,4-benzodiazepin-2-one
|
|
C16H15ClN2O |
详情 |
详情
|
(C) |
19273 |
acetyl chloride
|
75-36-5 |
C2H3ClO |
详情 | 详情
|
合成路线3
该中间体在本合成路线中的序号:
(B) 1) The alkylation of 2-amino-5-chlorobenzophenone (I) with 2,2,2-trifluoroethyl trichloromethansulfonate (II) in refluxing xylene gives the N-trifluoroethyl derivative (III), which is then cyclized with glycine ethyl ester (A) in refluxing pyridine.
2) Compound (III) can also be bromoacetylated with bromoacetyl bromide (B) in refluxing benzene yielding the N-bromoacetyl compound (IV), which is then cyclized with ammonia in CHCl3.
3) By alkylation of 7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one (IX) with NaOMe and 2,2,2-trifluoroethyl iodide in MeOH.
【1】
Topliss, J.G.; 2-Polyfluoroweralkyl benzophenones. US 3641147 .
|
【2】
Topliss, J.G.; 1-Polyhalogenoalkyl-2-oxo-1,3-dihydro-2H-14-benzodiazepines. US 3429874 .
|
【3】
Topliss, J.G.; Verfahren zur Herstellung von neuen 1,4-benzodiazepinen bzw. ihren 4-Oxyden. CH 505842; DE 1793682; FR 1518382; GB 1179125 .
|
【4】
Castaner, J.; Thorpe, P.; Halazepam. Drugs Fut 1978, 3, 2, 109.
|
【5】
Topliss, J.G.; Steinman, M.; Alekel, R.; Wong, Y.S.; York, E.E.; 1-Polyfluoroalkylbenzodiazepines. J Med Chem 1973, 16, 12, 1354-60.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
18806 |
1,1,1-trifluoro-2-iodoethane
|
353-83-3 |
C2H2F3I |
详情 | 详情
|
(A) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(B) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(I) |
10279 |
(2-Amino-5-chlorophenyl)(phenyl)methanone; 2-Amino-5-chlorobenzophenone
|
719-59-5 |
C13H10ClNO |
详情 | 详情
|
(II) |
33474 |
2,2,2-Trifluoroethyl trichloromethanesulfonate; 2,2,2-Trifluoroethyl trichloromethylsulfonate
|
23199-56-6 |
C3H2Cl3F3O3S |
详情 | 详情
|
(III) |
33848 |
[5-chloro-2-[(2,2,2-trifluoroethyl)amino]phenyl](phenyl)methanone
|
|
C15H11ClF3NO |
详情 |
详情
|
(IV) |
33849 |
N-(2-benzoyl-4-chlorophenyl)-2-bromo-N-(2,2,2-trifluoroethyl)acetamide
|
|
C17H12BrClF3NO2 |
详情 |
详情
|
(IX) |
10281 |
7-Chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one; 1,4-benzdiazepin-2-one-5-phenyl-7-chloro
|
1088-11-5 |
C15H11ClN2O |
详情 | 详情
|
合成路线4
该中间体在本合成路线中的序号:
(B) N-bromoacetyl compound (IV) can also be obtained by bromoacetylation of (XV) with bromoacetyl bromide (B) in refluxing benzene affording 4-chloro-N-bromoacetyl-N-(2,2,2-trifluoroethyl)aniline (XVI), followed by a Friedel-Crafts reaction with benzoyl chloride by means of AlCl3.
【1】
Topliss, J.G.; 2-Polyfluoroweralkyl benzophenones. US 3641147 .
|
【2】
Topliss, J.G.; 1-Polyhalogenoalkyl-2-oxo-1,3-dihydro-2H-14-benzodiazepines. US 3429874 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(D) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(B) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(IV) |
33849 |
N-(2-benzoyl-4-chlorophenyl)-2-bromo-N-(2,2,2-trifluoroethyl)acetamide
|
|
C17H12BrClF3NO2 |
详情 |
详情
|
(XV) |
33475 |
N-(4-chlorophenyl)-N-(2,2,2-trifluoroethyl)amine; 4-chloro-N-(2,2,2-trifluoroethyl)aniline
|
|
C8H7ClF3N |
详情 |
详情
|
(XVI) |
33852 |
2-bromo-N-(4-chlorophenyl)-N-(2,2,2-trifluoroethyl)acetamide
|
|
C10H8BrClF3NO |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(V) Condensation of the chiral 2-chloro-3-(alpha-methylbenzyl)tetrahydro-2H-1,3,2-oxaazaphosphorine 2-oxide (I) with 2-chloroethylamine (II) afforded the 2-(chloroethylamino) derivative (III). The chiral auxiliary group of (III) was then removed by catalytic hydrogenation with H2 over -Pd/C yielding (R)-2-(2-chloroethylamino)tetrahydro-2H-1,3,2-oxaazaphosphorine 2-oxide (IV). Acylation of (IV) with bromoacetyl bromide (V) in the presence of triethylamine hydrobromide furnished bromoacetamide (VI). The amide carbonyl group of (VI) was finally reduced by treatment with NaBH4 and BF3·Et2O.
【1】
Kinas, R.W.; Stec, W.J.; Kusnierczyk, H.; Misiura, K.; radzikowski, C.; (S)-(-)-Bromofosfamide (CBM-11): Synthesis and antitumor activity and cytotoxicity in mice. Anti-Cancer Drugs 2001, 12, 5, 453.
|
【2】
Kutner, A.; Grynkiewicz, G.; Stec, W.J.; Radzikowski, C.; Szelejeswki, W.; Kinas, R.; Misiura, K.; Grodner, J.; Kusnierczyk, H.; Pilichowska, S.; Process for the production of the derivs. of 1,3,2-oxazaphosphorinane. EP 0295576 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
56222 |
2-chloro-3-[(1S)-1-phenylethyl]-1,3,2lambda~5~-oxazaphosphinan-2-one
|
|
C11H15ClNO2P |
详情 |
详情
|
(II) |
33455 |
2-chloro-1-ethanamine; 2-chloroethylamine
|
|
C2H6ClN |
详情 |
详情
|
(III) |
56223 |
2-[(2-chloroethyl)amino]-3-[(1S)-1-phenylethyl]-1,3,2lambda~5~-oxazaphosphinan-2-one
|
|
C13H20ClN2O2P |
详情 |
详情
|
(IV) |
56224 |
2-[(2-chloroethyl)amino]-1,3,2lambda~5~-oxazaphosphinan-2-one
|
|
C5H12ClN2O2P |
详情 |
详情
|
(V) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(VI) |
56225 |
3-(2-bromoacetyl)-2-[(2-chloroethyl)amino]-1,3,2lambda~5~-oxazaphosphinan-2-one
|
|
C7H13BrClN2O3P |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(V) 2-Aminobenzophenone (I) is acylated with bromoacetyl bromide followed by reaction with ammonia to form the [1,4]benzodiazepine. N1-Methylation produces 1,3-dihydro-1-methyl-5-phenyl-2H-[1,4]benzodiazepin-2-one (II). Treatment with isoamyl nitrate and t-BuOK gives an oxime, which is reduced by catalytic hydrogenation to racemic 3-amino-benzodiazepine (III), which is isolated as the crystalline benzenesulfonic acid salt. Crystallization-induced asymmetric transformation yields 3(S)-(-)-3-amino-1,3-dihydro-1-methyl-5-phenyl-2H-[1,4]benzodiazepin-2-one (IV). Acylation with indole-2-carbonylimidazolide produces MK-329.
【1】
Reider, P.J.; Davis, P.; Grabowski, E.J.J.; Hughes, D.L.; Crystallization-induced asymmetric transformation: Stereospecific synthesis of a potent peripheral CCK antagonis. J Org Chem 1987, 52, 955.
|
【2】
Freidinger, R.M.; Berlin, R.G.; MK-329. Drugs Fut 1989, 14, 9, 862.
|
【3】
Veber, D.F.; Freidinger, R.M.; Hirshfield, J.; Rittle, K.E.; Springer, J.P.; DiPardo, R.M.; Bock, M.G.; Evans, B.E.; Synthesis and resolution of 3-amino-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-ones. J Org Chem 1987, 52, 3232.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
21101 |
(2-aminophenyl)(phenyl)methanone; 2-Aminobenzophenone
|
2835-77-0 |
C13H11NO |
详情 | 详情
|
(II) |
21319 |
1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
|
|
C16H14N2O |
详情 |
详情
|
(III) |
21320 |
3-Amino-1-methyl-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one benzenesulfonate
|
|
C22H21N3O4S |
详情 |
详情
|
(IV) |
21321 |
(3S)-3-amino-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
|
|
C16H15N3O |
详情 |
详情
|
(V) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(VI) |
21323 |
3,5-dichloro-2-hydroxybenzaldehyde; 3,5-Dichlorosalicylaldehyde
|
90-60-8 |
C7H4Cl2O2 |
详情 | 详情
|
(VII) |
21324 |
1H-imidazol-1-yl(1H-indol-2-yl)methanone
|
|
C12H9N3O |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(VIII) Several novel syntheses of 2-butyl-5-chloro-3H-imidazole-4-carbaldehyde (XI), a key intermediate in the synthesis of losartan, have been described:
1) Treatment of glycine methyl ester hydrochloride (I) with NaOH in methanol, followed by reaction with methyl pentanimidate (II), gives 2-butyl-4,5-dihydro-1H-imidazol-5-one (III), which is treated with POCl3 to give the 2-butyl-5-chloro-1H-imidazole (IV). Reaction of (IV) with POCl3 and DMF yields the enamine (V), which is finally hydrolyzed with water to 2-butyl-5-chloro-3H-imidazole-4-carbaldehyde (XI), the desired intemediate in the synthesis of losartan.
2) Imidazolinone (III) can also be obtained by cyclization of chloroacetic acid methyl ester (VI), chloroacetyl chloride (VII) or bromoacetyl bromide (VIII) with pentanamidine (IX) by means of NaOH in methanol.
3) Alternatively, imidazolinone (III) can be treated with dimethylformamide dimethylacetal in dichloromethane yielding the enamine (X), which is finally treated with POCl3 and hydrolyzed with water.
4) The reaction of glycine (XI) with methyl pentanimidate (II) in NaOH/MeOH gives amidine (XII), which, without isolation, is treated with POCl3 and DMF at 100 C for 2 h, and then hydrolyzed with water to give the desired 2-butyl-5-chloro-3H-imidazole-4-carbaldehyde.
Methyl pentanimidate (II) is obtained treating a solution of valeronitrile in MeOH with HCl gas followed by neutralization with aqueous KOH and extraction with Et2O.
【1】
Kohr, J.; Griffiths, G.J.; Imwinkelried, R.; Hauck, M.B.; Roten, C.A.; Stucky, G.C.; Novel syntheses of 2-butyl-5-chloro-3H-imidazole-4-carbaldehyde: A key intermediate for the synthesis of the angiotensin II antagonist losartan. J Org Chem 1999, 64, 22, 8084. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17568 |
methyl 2-aminoacetate
|
|
C3H7NO2 |
详情 |
详情
|
(II) |
34050 |
methyl pentanimidoate
|
|
C6H13NO |
详情 |
详情
|
(III) |
34051 |
2-butyl-3,5-dihydro-4H-imidazol-4-one
|
|
C7H12N2O |
详情 |
详情
|
(IV) |
34052 |
2-butyl-5-chloro-1H-imidazole
|
|
C7H11ClN2 |
详情 |
详情
|
(V) |
34053 |
N-[(2-butyl-5-chloro-4H-imidazol-4-ylidene)methyl]-N,N-dimethylamine; (2-butyl-5-chloro-4H-imidazol-4-ylidene)-N,N-dimethylmethanamine
|
|
C10H16ClN3 |
详情 |
详情
|
(VI) |
10257 |
methyl 2-chloroacetate; methyl chloroacetate
|
96-34-4 |
C3H5ClO2 |
详情 | 详情
|
(VII) |
11296 |
2-Chloroacetyl chloride; Chloroacetic chloride
|
79-04-9 |
C2H2Cl2O |
详情 | 详情
|
(VIII) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(IX) |
14576 |
pentanimidamide
|
109-51-3 |
C5H12N2 |
详情 | 详情
|
(X) |
34054 |
2-butyl-5-[(E)-(dimethylamino)methylidene]-3,5-dihydro-4H-imidazol-4-one
|
|
C10H17N3O |
详情 |
详情
|
(XI) |
13925 |
2-Butyl-4-chloro-1H-imidazole-5-carbaldehyde
|
83857-96-9 |
C8H11ClN2O |
详情 | 详情
|
(XII) |
20436 |
glycine
|
56-40-6 |
C2H5NO2 |
详情 | 详情
|
(XIII) |
34055 |
2-(pentanimidoylamino)acetic acid
|
|
C7H14N2O2 |
详情 |
详情
|
(XIV) |
13921 |
Pentanenitrile; n-Valeronitrile
|
110-59-8 |
C5H9N |
详情 | 详情
|
合成路线8
该中间体在本合成路线中的序号:
(VI) The condensation of 2-chlorobenzoyl chloride (I) with cyanacetic acid (II) by means of butyllithium in THF gives 2-(2-chlorobenzoyl)acetonitrile (III), which is cyclized with N-(ethoxycarbonyl)piperidin-4-one (IV) by means of S and morpholine in refluxing methanol yielding the bicyclic ethyl ester (V). The acylation of (V) with bromoacetyl bromide (VI) in chloroform affords the corresponding 2-(bromoacetamido) derivative (VII), which by reaction with dry ammonia in THF is converted into the 2-glycinamido derivative (VIII). The cyclization of (VIII) in refluxing pyridine gives the tricyclic ethyl ester (IX), which by reaction with P2S5 in refluxing pyridine is converted into the corresponding thioketone (X). The reaction of (X) with hydrazine in methanol yields the 2-hydrazino derivative (XI), which is acylated with acetyl chloride (XII) and NaHCO3 in THF affording the 2-(acetylhydrazino) derivative (XIII). The cyclization of (XIII) in refluxing acetic acid gives the tetracyclic ethyl ester (XIV), which is decarboxylated with 30% HBr yielding the tetracyclic precursor (XV). The acylation of (XV) with 2-(3,4-dimethoxyphenylthio)acetic acid (XVI) by means of dicyclohexylcarbodiimide (DCC) in DMF affords the acylated compound (XVII), which is finally treated with P2S5 or Lawesson's reagent.
【1】
Braquet, P.; Esanu, A.; Laurent, J.-P.; Pommier, J. (SCRAS (Societé de Conseils de Recherches et d'Applications Scientifiques)); Thieno-triazolo-diazepine derivs. and process for their preparation. BE 1004122; CH 681009; DE 4015137; FR 2646774; FR 2646851; GB 2231330; JP 1991005484; US 5049559 . |
【2】
Braquet,P.; Castaner, J.; Duverger, D.; Koltai, M.; Spinnewyn, B.; Pirotzky, E.; Esanu, A.; BN 50739. Drugs Fut 1991, 16, 5, 413.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
14000 |
o-Chlorobenzoyl chloride; 2-Chlorobenzoyl chloride
|
609-65-4 |
C7H4Cl2O |
详情 | 详情
|
(II) |
12591 |
Cyanoacetic Acid; 2-Cyanoacetic acid
|
372-09-8 |
C3H3NO2 |
详情 | 详情
|
(III) |
12923 |
3-(2-Chlorophenyl)-3-oxopropanenitrile
|
40018-25-5 |
C9H6ClNO |
详情 | 详情
|
(IV) |
13486 |
Ethyl 4-oxo-1-piperidinecarboxylate; N-Carbethoxy-4-piperidone
|
29976-53-2 |
C8H13NO3 |
详情 | 详情
|
(V) |
14004 |
ethyl 2-amino-3-(2-chlorobenzoyl)-4,7-dihydrothieno[2,3-c]pyridine-6(5H)-carboxylate
|
|
C17H17ClN2O3S |
详情 |
详情
|
(VI) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(VII) |
14006 |
ethyl 2-[(2-bromoacetyl)amino]-3-(2-chlorobenzoyl)-4,7-dihydrothieno[2,3-c]pyridine-6(5H)-carboxylate
|
|
C19H18BrClN2O4S |
详情 |
详情
|
(VIII) |
14007 |
ethyl 2-[(2-aminoacetyl)amino]-3-(2-chlorobenzoyl)-4,7-dihydrothieno[2,3-c]pyridine-6(5H)-carboxylate
|
|
C19H20ClN3O4S |
详情 |
详情
|
(IX) |
14008 |
ethyl 5-(2-chlorophenyl)-2-oxo-1,2,3,6,7,9-hexahydro-8H-pyrido[4',3':4,5]thieno[2,3-e][1,4]diazepine-8-carboxylate
|
|
C19H18ClN3O3S |
详情 |
详情
|
(X) |
14009 |
ethyl 5-(2-chlorophenyl)-2-thioxo-1,2,3,6,7,9-hexahydro-8H-pyrido[4',3':4,5]thieno[2,3-e][1,4]diazepine-8-carboxylate
|
|
C19H18ClN3O2S2 |
详情 |
详情
|
(XI) |
14010 |
ethyl 5-(2-chlorophenyl)-2-hydrazino-3,6,7,9-tetrahydro-8H-pyrido[4',3':4,5]thieno[2,3-e][1,4]diazepine-8-carboxylate
|
|
C19H20ClN5O2S |
详情 |
详情
|
(XII) |
14011 |
1-(Chlorooxy)-1-oxoethane
|
|
C2H3ClO2 |
详情 |
详情
|
(XIII) |
14012 |
ethyl 2-(2-acetylhydrazino)-5-(2-chlorophenyl)-3,6,7,9-tetrahydro-8H-pyrido[4',3':4,5]thieno[2,3-e][1,4]diazepine-8-carboxylate
|
|
C21H22ClN5O3S |
详情 |
详情
|
(XIV) |
14013 |
ethyl 6-(2-chlorophenyl)-1-methyl-7,10-dihydro-4H-pyrido[4',3':4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-9(8H)-carboxylate
|
|
C21H20ClN5O2S |
详情 |
详情
|
(XV) |
14014 |
6-(2-Chlorophenyl)-1-methyl-7,8,9,10-tetrahydro-4H-pyrido[4',3':4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
|
|
C18H16ClN5S |
详情 |
详情
|
(XVI) |
14015 |
2-[(3,4-Dimethoxyphenyl)sulfanyl]acetic acid
|
95735-63-0 |
C10H12O4S |
详情 | 详情
|
(XVII) |
14016 |
1-[6-(2-Chlorophenyl)-1-methyl-7,10-dihydro-4H-pyrido[4',3':4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-9(8H)-yl]-2-[(3,4-dimethoxyphenyl)sulfanyl]-1-ethanone
|
|
C28H26ClN5O3S2 |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(IV) Nitration of minocycline (I) with KNO3 and H2SO4 gives the 9-nitro derivative (II), which is reduced with H2 over Pd/C in 2-methoxyethanol/2N H2SO4 to provide 9-aminominocycline (III). Acylation of compound (III) with 2-bromoacetyl bromide (IV) in N,N-dimethylpropyleneurea (DMPU) affords 9-(2-bromoacetamido)minocycline (V). Finally, this compound is treated with tert-butylamine (VI) to yield, after purification, GAR-936.
【1】
Hunter, P.A.; Castaner, J.; GAR-936. Drugs Fut 2001, 26, 9, 851.
|
【2】
Sum, P.-E.; Petersen, P.; Synthesis and structure-activity relationship of novel glycylcline derivatives leading to the discovery of GAR-936. Bioorg Med Chem Lett 1999, 9, 10, 1459.
|
【3】
Sum, P.-E.; Lee, V.J. (American Cyanamid Co.); Method of producing 7-(substd.)-9-[(substd. glycyl)amidol]-6-demethyl-6-deoxytetracyclines. EP 0582790; US 5284963 .
|
【4】
Sum, P.-E.; Lee, V.J.; Testa, R.T.; Hlavka, J.J.; Ellestad, G.A.; Bloom, J.D.; Gluzman, Y.; Tally, F.P.; Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines. J Med Chem 1994, 37, 1, 184-8.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16360 |
(4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-2-naphthacenecarboxamide
|
10118-90-8 |
C23H27N3O7 |
详情 | 详情
|
(II) |
16361 |
(4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-9-nitro-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-2-naphthacenecarboxamide
|
|
C23H26N4O9 |
详情 |
详情
|
(III) |
16362 |
(4S,4aS,5aR,12aS)-9-amino-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-2-naphthacenecarboxamide
|
|
C23H28N4O7 |
详情 |
详情
|
(IV) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(V) |
48570 |
(4S,4aS,5aR,12aS)-9-[(2-bromoacetyl)amino]-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-2-naphthacenecarboxamide
|
|
C25H29BrN4O8 |
详情 |
详情
|
(VI) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(VII) |
48571 |
2-(tert-butylamino)acetyl chloride
|
|
C6H12ClNO |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(IX) 2) An improved procedure consisted of condensation of 5-nitroisatoic anhydride (I) with beta-alanine ethyl ester (V) to give amide (XIV). The amino group of (XIV) was protected with benzhydryl bromide (VII) yielding (XV), and then the nitro group of (XV) was reduced to aniline (XVI) by catalytic transfer hydrogenation. Protection of the amine of (XVI) as the tert-butyl carbamate (XVIII) was effected using 2-(tert-butoxycarbonyloxymino)-2-phenylacetonitrile (XVII). The sequence of condensation of (XVIII) with bromoacetyl bromide (IX), followed by cyclization of the intermediate bromoacetamide with DBU provided the benzodiazepinedione (XIX). Hydrogenolysis of the N-benzhydryl group of (XIX) in the presence of Pearlman's catalyst, followed by treatment with trimethylsilyl azide furnished the tetrazole (XX). The Boc group of (XX) was deprotected with trifluoroacetic acid, and subsequent coupling with 4-cyanobenzoyl chloride (III) gave amide (XXI). The cyano group was of (XXI) then converted to hydroxyamidine (XXII) with hydroxylamine. Catalytic hydrogenation of (XXII) in the presence of Ac2O and AcOH produced the corresponding amidine. Finally, the ester group was hydrolyzed with LiOH.
【1】
Robarge, K.D.; Dina, M.S.; Somers, T.C.; Lee, A.; Rawson, T.E.; Olivero, A.G.; Tischler, M.H.; Webb, R.R. II; Weese, K.J.; Aliagas, I.; Blackburn, B.K.; Preparation and biological activity of novel tricyclic GPIIb/IIIa antagonists. Bioorg Med Chem 1998, 6, 12, 2345. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22347 |
5-Nitroisatoic anhydride; 6-nitro-2H-3,1-benzoxazine-2,4(1H)-dione
|
4693-02-1 |
C8H4N2O5 |
详情 | 详情
|
(III) |
19280 |
4-cyanobenzoyl chloride
|
6068-72-0 |
C8H4ClNO |
详情 | 详情
|
(VII) |
17639 |
beta-Alanine, ethyl ester; ethyl 3-aminopropanoate
|
924-73-2 |
C5H11NO2 |
详情 | 详情
|
(IX) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(XIV) |
22360 |
ethyl 3-[(2-amino-5-nitrobenzoyl)amino]propanoate
|
|
C12H15N3O5 |
详情 |
详情
|
(XV) |
22361 |
ethyl 3-[[2-(benzhydrylamino)-5-nitrobenzoyl]amino]propanoate
|
|
C25H25N3O5 |
详情 |
详情
|
(XVI) |
22362 |
ethyl 3-[[5-amino-2-(benzhydrylamino)benzoyl]amino]propanoate
|
|
C25H27N3O3 |
详情 |
详情
|
(XVII) |
22363 |
2-[[(tert-butoxycarbonyl)oxy]imino]-2-phenylacetonitrile
|
58632-95-4 |
C13H14N2O3 |
详情 | 详情
|
(XVIII) |
22364 |
ethyl 3-([2-(benzhydrylamino)-5-[(tert-butoxycarbonyl)amino]benzoyl]amino)propanoate
|
|
C30H35N3O5 |
详情 |
详情
|
(XIX) |
22365 |
ethyl 3-[1-benzhydryl-7-[(tert-butoxycarbonyl)amino]-2,5-dioxo-1,2,3,5-tetrahydro-4H-1,4-benzodiazepin-4-yl]propanoate
|
|
C32H35N3O6 |
详情 |
详情
|
(XX) |
22366 |
ethyl 3-[8-[(tert-butoxycarbonyl)amino]-6-oxo-4H-[1,2,3,4]tetraazolo[1,5-a][1,4]benzodiazepin-5(6H)-yl]propanoate
|
|
C19H24N6O5 |
详情 |
详情
|
(XXI) |
22357 |
ethyl 3-[8-[(4-cyanobenzoyl)amino]-6-oxo-4H-[1,2,3,4]tetraazolo[1,5-a][1,4]benzodiazepin-5(6H)-yl]propanoate
|
|
C22H19N7O4 |
详情 |
详情
|
(XXII) |
22368 |
ethyl 3-[8-([4-[amino(hydroxyimino)methyl]benzoyl]amino)-6-oxo-4H-[1,2,3,4]tetraazolo[1,5-a][1,4]benzodiazepin-5(6H)-yl]propanoate
|
|
C22H22N8O5 |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(V) C1-C6 fragment.- The reaction of 3-methyl-2-butenylmagnesium chloride (I) with propanal (II) gives racemic 4,4-dimethyl-5-hexen-3-ol (III), which was submitted to enzymatic resolution with ChiroCLEC-PC dry enzyme yielding the (R) enantiomer (IV). The esterification of (IV) with bromoacetyl bromide (V) and dimethylaniline yields the corresponding ester (VI), which is oxidized with O3 and trimethyl phosphite and cyclized with SmI2 in THF to afford chiral tetrahydropyran-2-one (VII). The reduction of (VII) with Red-Al, followed by cyclization with 2-methoxypropene (VIII) and PPTS yields the acetonide (IX), which is finally oxidized with N-methylmorpholine-N-oxide and PPTS in dichloromethane giving the target intermediate (X).
【1】
Taylor, R.E.; et al.; A formal total synthesis of epothiolone A: Enantioselective preparation of the C1-C6 and C7-C12 fragments. J Org Chem 1998, 63, 25, 9580.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
27170 |
chloro(3-methyl-2-butenyl)magnesium
|
|
C5H9ClMg |
详情 |
详情
|
(II) |
15966 |
propionaldehyde
|
123-38-6 |
C3H6O |
详情 | 详情
|
(III) |
27171 |
4,4-dimethyl-5-hexen-3-ol
|
|
C8H16O |
详情 |
详情
|
(IV) |
27172 |
(3R)-4,4-dimethyl-5-hexen-3-ol
|
|
C8H16O |
详情 |
详情
|
(V) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(VI) |
27173 |
(1R)-1-ethyl-2,2-dimethyl-3-butenyl 2-bromoacetate
|
|
C10H17BrO2 |
详情 |
详情
|
(VII) |
27174 |
(4S,6R)-6-ethyl-4,5,5-trimethyltetrahydro-2H-pyran-2-one
|
|
C10H18O2 |
详情 |
详情
|
(VIII) |
17354 |
isopropenyl methyl ether; 2-methoxy-1-propene
|
116-11-0 |
C4H8O |
详情 | 详情
|
(IX) |
27175 |
(3R)-2-[(4S)-2,2-dimethyl-1,3-dioxan-4-yl]-2-methyl-3-pentanol
|
|
C12H24O3 |
详情 |
详情
|
(X) |
27176 |
2-[(4S)-2,2-dimethyl-1,3-dioxan-4-yl]-2-methyl-3-pentanone
|
|
C12H22O3 |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(XVIII) Condensation of 1,3-benzodioxole-5-carbaldehyde (XV) with nitromethane by means of ammonium acetate in HOAc gives the nitrostyrene (I), which is condensed with ethyl 2-(4-methoxybenzoyl)acetate (II) [obtained by reaction of acetophenone (XVI), diethyl carbonate and potassium tert-amyloxide] by means of NaOEt in THF to yield the 4-nitrobutyrate (III). Reductive cyclization of (III) with H2 over Raney-Ni in THF affords the (cis, cis)-pyrrolidine (VI), which is isomerized to the (trans,trans)-isomer (V) by means of NaOEt in refluxing ethanol. This racemic ester (V) is submitted to optical resolution with (S)-(+)-mandelic acid to provide the pure chiral ester (XVII). This compound is condensed with 2-bromo-N,N-dibutylacetamide (XIII) [obtained by reaction of 2-bromoacetyl bromide (XVIII) with dibutylamine (XIX) in toluene] by means of DIEA in acetonitrile to give the ethyl ester (XX), which is finally hydrolyzed with NaOH in hot ethanol.
【1】
Leeson, P.; Castañer, R.M.; Sorbera, L.A.; Castañer, J.; Atrasentan. Drugs Fut 2001, 26, 10, 939.
|
【2】
Winn, M.; Boyd, S.A.; Hutchins, C.W.; Tasker, A.S.; Von Geldern, T.W.; Kester, J.A.; Sorensen, B.K.; Szczepankiewicz, B.G.; Henry, K.J. Jr.; Liu, G.; Wittenberger, S.J.; King, S.A. (Abbott Laboratories Inc.); Novel benzo-1,3-dioxolyl- and benzofuranyl substd. pyrrolidine derivs. as endothelin antagonists. EP 0885215; WO 9730045 . |
【3】
Jae, H.-S.; Hutchins, C.W.; Szczepankiewicz, B.G.; King, S.A.; Winn, M.; Boyd, S.A.; Henry, K.J.; Geldern, T.W.; Wittenberger, S.J.; Tasker, A.S.; Sorensen, B.K.; Kester, J.A. (Abbott Laboratories Inc.); Endothelin antagonists. WO 9906397 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
20675 |
5-[(E)-2-nitroethenyl]-1,3-benzodioxole
|
1485-00-3 |
C9H7NO4 |
详情 | 详情
|
(II) |
20676 |
ethyl 3-(4-methoxyphenyl)-3-oxopropanoate
|
|
C12H14O4 |
详情 |
详情
|
(III) |
20677 |
ethyl 3-(1,3-benzodioxol-5-yl)-2-(4-methoxybenzoyl)-4-nitrobutanoate
|
|
C21H21NO8 |
详情 |
详情
|
(VI) |
20679 |
ethyl (2S,3R,4R)-4-(1,3-benzodioxol-5-yl)-2-(4-methoxyphenyl)-3-pyrrolidinecarboxylate
|
|
C21H23NO5 |
详情 |
详情
|
(XIII) |
20685 |
2-Bromo-N,N-dibutylacetamide; N,N-Dibutylbromoacetamide
|
|
C10H20BrNO |
详情 |
详情
|
(XV) |
10127 |
1,3-Benzodioxole-5-carbaldehyde; Heliotropine
|
120-57-0 |
C8H6O3 |
详情 | 详情
|
(XVI) |
11041 |
4-Methoxyacetophenone; 1-(4-Methoxyphenyl)-1-ethanone
|
100-06-1 |
C9H10O2 |
详情 | 详情
|
(XVII) |
20680 |
ethyl (2S,3S,4R)-4-(1,3-benzodioxol-5-yl)-2-(4-methoxyphenyl)-3-pyrrolidinecarboxylate
|
|
C21H23NO5 |
详情 |
详情
|
(XVIII) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(XIX) |
33492 |
N,N-dibutylamine; N-butyl-1-butanamine
|
111-92-2 |
C8H19N |
详情 | 详情
|
(XX) |
48687 |
ethyl (2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)-3-pyrrolidinecarboxylate
|
|
C31H42N2O6 |
详情 |
详情
|
合成路线13
该中间体在本合成路线中的序号:
(IV) The condensation of 2-methylaniline (I) with 2-fluorobenzonitrile (II) by means of BCl3 and AlCl3 gives 2-amino-2'-fluoro-3-methylbenzophenone (III), which is acylated at the amino group with bromoacetyl bromide (IV) in pyridine yielding the bromoacetamide (V). The cyclization of (V) with hydroxylamine and NaOH affords the benzodiazepinone-N-oxide (VI), which is treated with acetic anhydride to provide 3-acetoxy-5-(2-fluorophenyl)-9-methyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one (VII). The reaction of (VII) with potassium phthalimide (VIII) and NaI gives the phthalimido derivative (IX), which by cleavage with hydrazine yields 3-amino-5-(2-fluorophenyl)-9-methyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one (X). The protection of the amino group of (X) with Boc2O and TEA affords the carbamate (XI), which is alkylated with ethyl bromoacetate (XII) by means of NaH giving the ethoxycarbonylmethyl derivative (XIII). The hydrolysis of (XIII) with NaOH affords the corresponding carboxymethyl derivative (XIV), which is condensed with 3-azabicyclo[3,2,2]nonane (XV) by means of HOBT, WSCD and TEA to give the expected amide (XVI). The cleavage of the tert-butoxycarbonyl group of (XVI) with HCl yields the amine (XVII), which is finally condensed with the activated carbamate (XVIII) to furnish the title compound.
【1】
Toyoda, T.; Adachi, M.; Sugasawa, T.; et al.; Aminohaloborane in organic synthesis. I. Specific ortho substitution reaction of anilines. J Am Chem Soc 1978, 100, 4842.
|
【2】
Satoh, Y.; Tabuchi, S.; Mitsui, H.; Design of dual CCK-A and CCK-B receptor antagonists. Drugs Fut 1997, 22, 10, 1117.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
15511 |
o-toluidine; 2-methylphenylamine;2-Methylaniline;2-Aminotoluene;1-Amino-2-methylbenzene;1-Methyl-2-aminobenzene; ortho-Toluidine |
95-53-4 |
C7H9N |
详情 | 详情
|
(II) |
41199 |
2-fluorobenzonitrile
|
394-47-8 |
C7H4FN |
详情 | 详情
|
(III) |
41200 |
(2-amino-3-methylphenyl)(2-fluorophenyl)methanone
|
|
C14H12FNO |
详情 |
详情
|
(IV) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(V) |
41201 |
2-bromo-N-[2-(2-fluorobenzoyl)-6-methylphenyl]acetamide
|
|
C16H13BrFNO2 |
详情 |
详情
|
(VI) |
41202 |
5-(2-fluorophenyl)-9-methyl-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-4-ium-4-olate
|
|
C16H13FN2O2 |
详情 |
详情
|
(VII) |
41203 |
5-(2-fluorophenyl)-9-methyl-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-yl acetate
|
|
C18H15FN2O3 |
详情 |
详情
|
(VIII) |
27890 |
Potassium phthalimide
|
1074-82-4 |
C8H4KNO2 |
详情 | 详情
|
(IX) |
41204 |
2-[5-(2-fluorophenyl)-9-methyl-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]-1H-isoindole-1,3(2H)-dione
|
|
C24H16FN3O3 |
详情 |
详情
|
(X) |
41205 |
3-amino-5-(2-fluorophenyl)-9-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
|
|
C16H14FN3O |
详情 |
详情
|
(XI) |
41206 |
tert-butyl 5-(2-fluorophenyl)-9-methyl-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-ylcarbamate
|
|
C21H22FN3O3 |
详情 |
详情
|
(XII) |
16640 |
Ethyl 2-bromoacetate; Ethyl bromoacetate
|
105-36-2 |
C4H7BrO2 |
详情 | 详情
|
(XIII) |
41207 |
ethyl 2-[3-[(tert-butoxycarbonyl)amino]-5-(2-fluorophenyl)-9-methyl-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-1-yl]acetate
|
|
C25H28FN3O5 |
详情 |
详情
|
(XIV) |
41208 |
2-[3-[(tert-butoxycarbonyl)amino]-5-(2-fluorophenyl)-9-methyl-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-1-yl]acetic acid
|
|
C23H24FN3O5 |
详情 |
详情
|
(XV) |
41209 |
3-azabicyclo[3.2.2]nonane
|
|
C8H15N |
详情 |
详情
|
(XVI) |
41210 |
tert-butyl 1-[2-(3-azabicyclo[3.2.2]non-3-yl)-2-oxoethyl]-5-(2-fluorophenyl)-9-methyl-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-ylcarbamate
|
|
C31H37FN4O4 |
详情 |
详情
|
(XVII) |
41211 |
3-amino-1-[2-(3-azabicyclo[3.2.2]non-3-yl)-2-oxoethyl]-5-(2-fluorophenyl)-9-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
|
|
C26H29FN4O2 |
详情 |
详情
|
(XVIII) |
41212 |
4-nitrophenyl 3-(1H-1,2,3,4-tetraazol-5-yl)phenylcarbamate
|
|
C14H10N6O4 |
详情 |
详情
|
合成路线14
该中间体在本合成路线中的序号:
Condensation of piperonal (I) with nitromethane in the presence of ammonium acetate in AcOH provided nitrostyrene (II). Ketoester (IV) was prepared by carbethoxylation of 4'-propoxyacetophenone (III) with diethyl carbonate. Subsequent conjugate addition of ketoester (IV) to nitrostyrene (II) using DBU provided adduct (V). Hydrogenation of the nitro group of (V) over Raney Nickel, with concomitant ring closure formed the cyclic imine (VI), and further reduction of (VI) with NaBH3CN yielded the corresponding pyrrolidine as a diastereomeric mixture. Chromatographic separation removed the cis,cis isomer, affording a mixture of trans,trans and cis,trans pyrrolidines (VIIa, VIIb). 2,6-Diethylbromoacetanilide (IX) was prepared by acylation of 2,6-diethylaniline (VIII) with bromoacetyl bromide. N-Alkylation of the mixture of pyrrolidines (VIIa, VIIb) with bromoacetanilide (IX) furnished (Xa, Xb).
【1】
Sorensen, B.K.; Tasker, A.S.; von Geldern, T.W.; et al.; Pyrrolide-3-carboxylic acids as endothelin antagonists. 4. Side chain conformational restriction leads to ETB selectivity. J Med Chem 1999, 42, 18, 3668.
|
【2】
Tasker, A.S.; Boyd, S.A.; Sorensen, B.K.; Winn, M.; Jae, H.-S.; Von Geldern, T.W.; Henry, K.J. (Abbott Laboratories Inc.); 4-(Benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivs. as endothelin antagonists. EP 0888340; JP 2000504727; WO 9730046 . |
【3】
Tasker, A.S.; Henry, K.J.; Boyd, S.A.; Von Geldern, T.W.; Sorensen, B.K.; Jae, H.-S.; Winn, M. (Abbott Laboratories Inc.); Pyrrolidine carboxylic acid derivs. as endothelin antagonists. EP 0991620; WO 9857933 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
|
17470 |
diethyl carbonate; diethylcarbonate
|
105-58-8 |
C5H10O3 |
详情 | 详情
|
|
39563 |
nitromethane
|
75-52-5 |
CH3NO2 |
详情 | 详情
|
(VIIa) |
35056 |
ethyl (2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-2-(4-propoxyphenyl)-3-pyrrolidinecarboxylate
|
|
C23H27NO5 |
详情 |
详情
|
(VIIb) |
35057 |
ethyl (2S,3R,4S)-4-(1,3-benzodioxol-5-yl)-2-(4-propoxyphenyl)-3-pyrrolidinecarboxylate
|
|
C23H27NO5 |
详情 |
详情
|
(Xa) |
35060 |
ethyl (2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-1-[2-(2,6-diethylanilino)-2-oxoethyl]-2-(4-propoxyphenyl)-3-pyrrolidinecarboxylate
|
|
C35H42N2O6 |
详情 |
详情
|
(Xb),(XI) |
35061 |
ethyl (2S,3R,4S)-4-(1,3-benzodioxol-5-yl)-1-[2-(2,6-diethylanilino)-2-oxoethyl]-2-(4-propoxyphenyl)-3-pyrrolidinecarboxylate
|
|
C35H42N2O6 |
详情 |
详情
|
(I) |
10127 |
1,3-Benzodioxole-5-carbaldehyde; Heliotropine
|
120-57-0 |
C8H6O3 |
详情 | 详情
|
(II) |
20675 |
5-[(E)-2-nitroethenyl]-1,3-benzodioxole
|
1485-00-3 |
C9H7NO4 |
详情 | 详情
|
(III) |
35052 |
1-(4-propoxyphenyl)-1-ethanone
|
|
C11H14O2 |
详情 |
详情
|
(IV) |
35053 |
ethyl 3-oxo-3-(4-propoxyphenyl)propanoate
|
|
C14H18O4 |
详情 |
详情
|
(V) |
35054 |
ethyl 3-(1,3-benzodioxol-5-yl)-4-nitro-2-(4-propoxybenzoyl)butanoate
|
|
C23H25NO8 |
详情 |
详情
|
(VI) |
35055 |
ethyl 3-(1,3-benzodioxol-5-yl)-5-(4-propoxyphenyl)-3,4-dihydro-2H-pyrrole-4-carboxylate
|
|
C23H25NO5 |
详情 |
详情
|
(VIII) |
35058 |
2,6-diethylphenylamine; 2,6-diethylaniline
|
579-66-8 |
C10H15N |
详情 | 详情
|
(IX) |
35059 |
2-bromo-N-(2,6-diethylphenyl)acetamide
|
|
C12H16BrNO |
详情 |
详情
|
合成路线15
该中间体在本合成路线中的序号:
(XI) The deprotection of the resin (I) with piperidine in DMF gives the amino-resin (II), which is condensed with N-Fmoc-L-proline (III) by means of diisopropylcarbodiimide (DIC) in DMF to yield the anchored proline (IV). The deprotection of (IV) with piperidine in DMF affords compound (V) with a free NH group, which is condensed with 2-bromoacetic acid (VI) by means of DIC DMF to provide the bromoacetyl proline resin (VII). The condensation of (VII) with 6-(2-aminoethylamino)pyridine-3-carbonitrile (VIII) in DMSO to give the resin anchored precursor (IX), which is finally cleaved by means of trifluoroacetic anhydride (TFAA) in THF to furnish the target pyrrolidine-carbonitrile.
Alternatively, the acylation of L-prolinamide (X) with 2-bromoacetyl bromide (XI) by means of TEA and DMAP in dichloromethane gives the 1-(2-bromoacetyl)-L-prolinamide (XII), which is dehydrated by means of TFAA in dichloromethane to yield the pyrrolidine-carbonitrile (XIII). Finally, this compound is condensed with 6-(2-aminoethylamino)pyridine-3-carbonitrile (VIII) in THF to furnish the target pyrrolidine-carbonitrile.
【1】
Mangold, B.L.; Mone, M.D.; Dunning, B.E.; Russell, M.E.; Brinkman, J.A.; Weldon, S.C.; Hughes, T.E.; Naderi, G.B.; Villhauer, E.B.; 1-[2-[(5-Cyanopyridin-2-yl)amino]-ethylamino]acetyl-2-(S)-pyrrolidine-carbonitrile: A potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties. J Med Chem 2002, 45, 12, 2362. |
【2】
Villhauer, E.B. (Novartis AG); N-Substd. 2-cyanopyrrolidines. JP 2000511559; WO 9819998 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(V),(X) |
36137 |
(2S)-2-pyrrolidinecarboxamide;L-prolinamide |
7531-52-4 |
C5H10N2O |
详情 | 详情
|
(VII),(XII) |
54331 |
(2S)-1-(2-bromoacetyl)-2-pyrrolidinecarboxamide
|
n/a |
C7H11BrN2O2 |
详情 | 详情
|
(I) |
28722 |
9H-fluoren-9-ylmethyl carbamate
|
84418-43-9 |
C15H13NO2 |
详情 | 详情
|
(III) |
34762 |
(2S)-1-[(9H-fluoren-9-ylmethoxy)carbonyl]-2-pyrrolidinecarboxylic acid
|
71989-31-6 |
C20H19NO4 |
详情 | 详情
|
(IV) |
42841 |
9H-fluoren-9-ylmethyl (2R)-2-(aminocarbonyl)-1-pyrrolidinecarboxylate
|
|
C20H20N2O3 |
详情 |
详情
|
(VI) |
23660 |
2-Bromoacetic acid
|
79-08-3 |
C2H3BrO2 |
详情 | 详情
|
(VIII) |
54332 |
6-[(2-aminoethyl)amino]nicotinonitrile
|
n/a |
C8H10N4 |
详情 | 详情
|
(IX) |
54333 |
(2S)-1-[2-({2-[(5-cyano-2-pyridinyl)amino]ethyl}amino)acetyl]-2-pyrrolidinecarboxamide
|
n/a |
C15H20N6O2 |
详情 | 详情
|
(XI) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(XIII) |
54334 |
(2S)-1-(2-bromoacetyl)-2-pyrrolidinecarbonitrile
|
n/a |
C7H9BrN2O |
详情 | 详情
|
合成路线16
该中间体在本合成路线中的序号:
(XX) The reaction of 3-methyl-2-butenylmagnesium bromide (XVI) with propanal (XVII) gives racemic hexenol (XVIII), which is submitted to enzymatic resolution with ChiroCLEC-PC dry enzyme, yielding the R-enantiomer (XIX). The esterification of (XIX) with bromoacetyl bromide (XX) and dimethylaniline (DMA) affords the corresponding ester (XXI), which is oxidized with O3 and trimethyl phosphite and cyclized with SmI2 in THF to provide the chiral tetrahydropyranone (XXII). The reduction of (XXII) with Red-Al, followed by cyclization with 2-methoxypropene (XXIII) and PPTS, gives the acetonide (XXIV), which is oxidized with PPTS and NMO to provide the protected dihydroxyketone (XXV). The condensation of the ketone (XXV) with 2(S)-methyl-6-heptenal (XXVI) by means of LDA in THF gives the hydroxyundecenone (XXVII), which is treated with pyridinium p-toluenesulfonate (PPTS) in methanol to cleave the 1,3-dioxane ring and yield the trihydroxy compound (XXVIII). The silylation of (XXVIII) with Tbdms-OTf and lutidine in dichloromethane affords the fully silylated compound (XXIX), which is selectively monodesilylated with CSA to provide the primary alcohol (XXX). Finally, this alcohol is oxidized by means of pyridinium dichromate (PDC) in DMF to furnish the target tridecenoic acid intermediate (XII).
【1】
Schinzer, D.; et al.; Total synthesis of (-)-epothilone A. Angew Chem. Int Ed Engl 1997, 36, 5, 523.
|
【2】
Taylor, R.E.; et al.; A formal total synthesis of epothiolone A: Enantioselective preparation of the C1-C6 and C7-C12 fragments. J Org Chem 1998, 63, 25, 9580.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XVI) |
27170 |
chloro(3-methyl-2-butenyl)magnesium
|
|
C5H9ClMg |
详情 |
详情
|
(XVII) |
15966 |
propionaldehyde
|
123-38-6 |
C3H6O |
详情 | 详情
|
(XVIII) |
27171 |
4,4-dimethyl-5-hexen-3-ol
|
|
C8H16O |
详情 |
详情
|
(XIX) |
27172 |
(3R)-4,4-dimethyl-5-hexen-3-ol
|
|
C8H16O |
详情 |
详情
|
(XX) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(XXI) |
27173 |
(1R)-1-ethyl-2,2-dimethyl-3-butenyl 2-bromoacetate
|
|
C10H17BrO2 |
详情 |
详情
|
(XXII) |
27174 |
(4S,6R)-6-ethyl-4,5,5-trimethyltetrahydro-2H-pyran-2-one
|
|
C10H18O2 |
详情 |
详情
|
(XXIII) |
17354 |
isopropenyl methyl ether; 2-methoxy-1-propene
|
116-11-0 |
C4H8O |
详情 | 详情
|
(XXIV) |
27175 |
(3R)-2-[(4S)-2,2-dimethyl-1,3-dioxan-4-yl]-2-methyl-3-pentanol
|
|
C12H24O3 |
详情 |
详情
|
(XXV) |
27176 |
2-[(4S)-2,2-dimethyl-1,3-dioxan-4-yl]-2-methyl-3-pentanone
|
|
C12H22O3 |
详情 |
详情
|
(XXVI) |
27185 |
(2S)-2-methyl-6-heptenal
|
|
C8H14O |
详情 |
详情
|
(XXVII) |
44434 |
(4R,5S,6S)-2-[(4S)-2,2-dimethyl-1,3-dioxan-4-yl]-5-hydroxy-2,4,6-trimethyl-10-undecen-3-one
|
|
C20H36O4 |
详情 |
详情
|
(XXVIII) |
44435 |
(3S,6R,7S,8S)-1,3,7-trihydroxy-4,4,6,8-tetramethyl-12-tridecen-5-one
|
|
C17H32O4 |
详情 |
详情
|
(XXIX) |
44436 |
(5S,6R,9S)-9-[[tert-butyl(dimethyl)silyl]oxy]-2,2,3,3,6,8,8,13,13,14,14-undecamethyl-5-[(1S)-1-methyl-5-hexenyl]-4,12-dioxa-3,13-disilapentadecan-7-one
|
|
C35H74O4Si3 |
详情 |
详情
|
(XXX) |
44437 |
(5S,8R,9S)-5-(2-hydroxyethyl)-2,2,3,3,6,6,8,11,11,12,12-undecamethyl-9-[(1S)-1-methyl-5-hexenyl]-4,10-dioxa-3,11-disilatridecan-7-one
|
|
C29H60O4Si2 |
详情 |
详情
|
(XXX) |
44438 |
(3S,6R,7S,8S)-3,7-bis[[tert-butyl(dimethyl)silyl]oxy]-4,4,6,8-tetramethyl-5-oxo-12-tridecenoic acid
|
|
C29H58O5Si2 |
详情 |
详情
|
合成路线17
该中间体在本合成路线中的序号:
Selective acylation of the silyl ester of prostaglandin E2 (V) at C-15 hydroxyl group with bromoacetyl bromide in the presence of pyridine at -25 C afforded bromoacetate ester (VI). Then, displacement of the halogen atom with thiol (IV) in aqueous dioxan furnished the correspondig desilylated sulfide. This was finally converted into the title disodium phosphonate salt by treatment with cation exchange resin.
【1】
Gil, L.; et al.; Prostaglandin E2-bisphosphonate conjugates: Potential agents for treatment of osteoporosis. Bioorg Med Chem 1999, 7, 5, 901.
|
【2】
Gil, L.; Young, R.N.; Ruel, R.; Han, Y. (Merck Frosst Canada Inc.); Prostaglandin conjugates for treating or preventing bone disease. US 6121253; WO 0031084 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(IV) |
27983 |
1-phosphono-4-sulfanylbutylphosphonic acid
|
|
C4H12O6P2S |
详情 |
详情
|
(V) |
27984 |
tert-butyl(diphenyl)silyl (Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxy-1-octenyl]-5-oxocyclopentyl]-5-heptenoate
|
|
C36H50O5Si |
详情 |
详情
|
(VI) |
27985 |
tert-butyl(diphenyl)silyl (Z)-7-((1R,2R,3R)-2-[(E,3S)-3-[(2-bromoacetyl)oxy]-1-octenyl]-3-hydroxy-5-oxocyclopentyl)-5-heptenoate
|
|
C38H51BrO6Si |
详情 |
详情
|
合成路线18
该中间体在本合成路线中的序号:
(II) The acylation of m-difluorobenzene (I) with 2-bromoacetyl bromide (II) by means of AlCl3 gives the phenacyl bromide (III), which is treated with ethylmercaptan (IV) and K2CO3 to yield the sulfanyl derivative (V). The fluorination of (V) with N-fluoro-4-methylpyridinium-2-sulfonate affords the difluoroacetyl derivative (VI). The methylenation of the carbonyl group of (VI) with trimethylsulfoxonium iodide provides the oxiranyl derivative (VII), which is opened with 1,2,4-triazole (VIII) and K2CO3, furnishing the propanol derivative (IX). The oxidation of the sulfanyl group of (IX) by means of H2O2 or MCPBA gives the corresponding sulfonyl derivative (X). Finally, the racemic mixture (X) is submitted to optical resolution by crystallization of the (+)-3-bromocamphorsulfonic acid.
Alternatively, intermediate (VI) can be obtained as follows: The reaction of 2-chloro-2,2-difluoroacetic acid ethyl ester (XI) with ethylmercaptan (IV) by means of NaH gives the sulfanyl derivative (XII), which is finally condensed with 2,4-difluorobromobenzene (XIII) by means of BuLi to afford the desired intermediate (VI).
【1】
Kaneko, Y.; Takeda, S.; Eto, H.; et al.; New antifungal 1,2,4-triazoles with difluoro(substituted sulfonyl)methyl moiety. Chem Pharm Bull 2001, 49, 2, 173.
|
【2】
Sato, S.; Kaneko, Y.; Takeda, S.; Eto, H.; Tokizawa, M.; SS750, a new triazole agent: Structure-activity relationship of novel triazole-containing gem-difluoromethylsulfonyl moiety. 40th Intersci Conf Antimicrob Agents Chemother (Sept 17 2000, Toronto) 2000, Abst F-1080. |
【3】
Matsumoto, M.; Kaneko, Y.; Maebashi, K.; Takeda, S.; Sato, S.; Tokizawa, M.; Ishida, K.; Eto, H.; Asaoka, T. (SSP Co., Ltd.); Triazole deriv. or salt thereof, preparation process thereof as well as pharmaceutical containing said cpd.. CA 2256060; EP 0927719; JP 1999240871; US 6083968 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13095 |
m-Difluorobenzene; 1,3-Difluorobenzene
|
372-18-9 |
C6H4F2 |
详情 | 详情
|
(II) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(III) |
47646 |
2-bromo-1-(2,4-difluorophenyl)-1-ethanone
|
|
C8H5BrF2O |
详情 |
详情
|
(IV) |
23712 |
1-ethanethiol; ethylhydrosulfide
|
75-08-1 |
C2H6S |
详情 | 详情
|
(V) |
47647 |
1-(2,4-difluorophenyl)-2-(ethylsulfanyl)-1-ethanone
|
|
C10H10F2OS |
详情 |
详情
|
(VI) |
47648 |
1-(2,4-difluorophenyl)-2-(ethylsulfanyl)-2,2-difluoro-1-ethanone
|
|
C10H8F4OS |
详情 |
详情
|
(VII) |
47649 |
2-(2,4-difluorophenyl)-2-[(ethylsulfanyl)(difluoro)methyl]oxirane; [2-(2,4-difluorophenyl)-2-oxiranyl](difluoro)methyl ethyl sulfide
|
|
C11H10F4OS |
详情 |
详情
|
(VIII) |
13135 |
1H-1,2,4-Triazole; 1,2,4-Triazole
|
288-88-0 |
C2H3N3 |
详情 | 详情
|
(IX) |
47650 |
2-(2,4-difluorophenyl)-1-(ethylsulfanyl)-1,1-difluoro-3-(1H-1,2,4-triazol-1-yl)-2-propanol
|
|
C13H13F4N3OS |
详情 |
详情
|
(X) |
47651 |
2-(2,4-difluorophenyl)-1-(ethylsulfonyl)-1,1-difluoro-3-(1H-1,2,4-triazol-1-yl)-2-propanol
|
|
C13H13F4N3O3S |
详情 |
详情
|
(XI) |
47652 |
Chlorodifluoroacetic acid ethyl ester; Difluorochloroacetic acid ethyl ester; Ethyl chlorodifluoroacetate; ethyl 2-chloro-2,2-difluoroacetate
|
383-62-0 |
C4H5ClF2O2 |
详情 | 详情
|
(XII) |
47653 |
ethyl 2-(ethylsulfanyl)-2,2-difluoroacetate
|
|
C6H10F2O2S |
详情 |
详情
|
(XIII) |
15488 |
1-bromo-2,4-difluorobenzene
|
348-57-2 |
C6H3BrF2 |
详情 | 详情
|
合成路线19
该中间体在本合成路线中的序号:
(IV) Treatment of 2,2'-dimethylbenzophenone (I) with hydroxylamine afforded oxime (II), which was reduced to the benzhydryl amine (III) with sodium metal in liquid ammonia. Condensation of (III) with bromoacetyl bromide (IV) then produced the target amide (V).
【1】
Chiou, W.J.; Liu, G.; Kozmina, N.S.; Opgenorth, T.J.; Winn, M.; Dixon, D.B.; Nguyen, B.; von geldern, T.W.; Marsh, K.C.; Design, synthesis, and activity of a series of pyrrolidine-3-carboxylic acid-based, highly specific, orally active ETB antagonists containing a diphenylmethylamine acetamide side chain. J Med Chem 1999, 42, 18, 3679. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
32201 |
Hydroxylamine
|
7803-49-8 |
H3NO |
详情 | 详情
|
(I) |
35192 |
bis(2-methylphenyl)methanone
|
|
C15H14O |
详情 |
详情
|
(II) |
35193 |
bis(2-methylphenyl)methanone oxime
|
|
C15H15NO |
详情 |
详情
|
(III) |
35194 |
bis(2-methylphenyl)methanamine; bis(2-methylphenyl)methylamine
|
|
C15H17N |
详情 |
详情
|
(IV) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(V) |
35195 |
N-[bis(2-methylphenyl)methyl]-2-bromoacetamide
|
|
C17H18BrNO |
详情 |
详情
|
合成路线20
该中间体在本合成路线中的序号:
3-Aminobenzoic acid (I) was protected as the trifluoroacetamide (II) using trifluoroacetic anhydride and then converted to acid chloride (III) by means of SOCl2. Subsequent condensation of (III) with urea provided 3-(trifluoroacetamido)benzoylurea (IV). After cleavage of the trifluoroacetamido group of (IV) by treatment with methanolic n-butylamine, the deprotected aniline (V) was coupled with bromoacetyl bromide in DMA to furnish the title bromoacetamide.
【1】
Bekesi, J.G.; Holland, J.F.; Jiang, J.-D.; Ma, L.; Roboz, J.; Deng, L.; Weisz, I.; Synthesis, cancericidal and antimicrotubule activities of 3-(haloacetamido)-benzoylureas. Anti-Cancer Drug Des 1998, 13, 7, 735.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
|
19310 |
urea
|
57-13-6 |
CH4N2O |
详情 | 详情
|
(I) |
26638 |
3-Aminobenzoic acid
|
99-05-8 |
C7H7NO2 |
详情 | 详情
|
(II) |
26639 |
3-[(2,2,2-trifluoroacetyl)amino]benzoic acid
|
|
C9H6F3NO3 |
详情 |
详情
|
(III) |
26640 |
3-[(2,2,2-trifluoroacetyl)amino]benzoyl chloride
|
|
C9H5ClF3NO2 |
详情 |
详情
|
(IV) |
26641 |
N-(3-[[(aminocarbonyl)amino]carbonyl]phenyl)-2,2,2-trifluoroacetamide
|
|
C10H8F3N3O3 |
详情 |
详情
|
(V) |
26642 |
N-(3-aminobenzoyl)urea
|
|
C8H9N3O2 |
详情 |
详情
|
合成路线21
该中间体在本合成路线中的序号:
(XI) Regioselective coupling of the 2-arylpiperazine (IV) with 3,5-dimethylbenzoic acid (IX) at the less hindered N atom by means of EDC and HOBt afforded the 4-benzoyl piperazine (X). This was subsequently acylated with bromoacetyl bromide (XI) to yield the bromo amide (XII). Bromide displacement in (XII) with 4-amino-1-benzylpiperidine (XIII) then gave the title compound.
【1】
Shue, H.-J.; Shih, N.-Y.; Blythin, D.J.; Chen, X.; Tom, W.C.; Piwinski, J.J.; McCormick, K.D. (Schering Corp.); Piperazino derivs. as neurokinin antagonists. EP 0823906; US 5719156; WO 9634864 .
|
【2】
Piwinski, J.J.; McCormick, K.D.; Shue, H.-J.; Chen, X.; Shih, N.-Y.; Blythin, D.J. (Schering Corp.); Piperazino derivs. as neurokinin antagonists. EP 0850236; JP 2000344766; US 5795894; US 5892039; WO 9708166 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IV) |
47946 |
2-(3,4-dichlorophenyl)piperazine
|
|
C10H12Cl2N2 |
详情 |
详情
|
(IX) |
26775 |
3,5-dimethylbenzoic acid
|
499-06-9 |
C9H10O2 |
详情 | 详情
|
(X) |
47950 |
[3-(3,4-dichlorophenyl)-1-piperazinyl](3,5-dimethylphenyl)methanone
|
|
C19H20Cl2N2O |
详情 |
详情
|
(XI) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(XIII) |
34808 |
1-Benzyl-4-piperidinylamine; 1-Benzyl-4-piperidinamine; 4-Amino-1-benzylpiperidine
|
50541-93-0 |
C12H18N2 |
详情 | 详情
|
合成路线22
该中间体在本合成路线中的序号:
(XI) In a related method, the 2-arylpiperazine (IV) was first protected as the 4-tert-butyl carbamate (XIV) upon treatment with di-tert-butyl dicarbonate in MeOH at -78 C. Subsequent acylation of (XIV) with bromoacetyl bromide (XI) produced the bromo amide (XV), which was then condensed with the aminopiperidine (XIII), yielding the glycinamide derivative (XVI). Acidic cleavage of the Boc group of (XVI) afforded the 1-acyl piperazine (XVII). This was finally coupled with 3,5-dimethylbenzoic acid using EDC and HOBt.
【1】
Anthes, J.C.; McPhail, A.T.; Blythin, D.J.; Shue, H.-J.; Chen, X.; Piwinski, J.J.; shih, N.-Y.; Discovery of Sch 62373 and analogs, of novel series of 2-phenylpiperazines exhibiting potent dual NK1/NK2 antagonist activity. 221st ACS Natl Meet (April 1 2001, San Diego) 2001, Abst MEDI 244. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IV) |
47946 |
2-(3,4-dichlorophenyl)piperazine
|
|
C10H12Cl2N2 |
详情 |
详情
|
(IX) |
26775 |
3,5-dimethylbenzoic acid
|
499-06-9 |
C9H10O2 |
详情 | 详情
|
(XI) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(XIII) |
34808 |
1-Benzyl-4-piperidinylamine; 1-Benzyl-4-piperidinamine; 4-Amino-1-benzylpiperidine
|
50541-93-0 |
C12H18N2 |
详情 | 详情
|
(XIV) |
47952 |
tert-butyl 3-(3,4-dichlorophenyl)-1-piperazinecarboxylate
|
|
C15H20Cl2N2O2 |
详情 |
详情
|
(XV) |
47953 |
tert-butyl 4-(2-bromoacetyl)-3-(3,4-dichlorophenyl)-1-piperazinecarboxylate
|
|
C17H21BrCl2N2O3 |
详情 |
详情
|
(XVI) |
47954 |
tert-butyl 4-[2-[(1-benzyl-4-piperidinyl)amino]acetyl]-3-(3,4-dichlorophenyl)-1-piperazinecarboxylate
|
|
C29H38Cl2N4O3 |
详情 |
详情
|
(XVII) |
47955 |
2-[(1-benzyl-4-piperidinyl)amino]-1-[2-(3,4-dichlorophenyl)-1-piperazinyl]-1-ethanone
|
|
C24H30Cl2N4O |
详情 |
详情
|
合成路线23
该中间体在本合成路线中的序号:
(XV) An alternative route to the intermediate bromide (IX) has been reported. Condensation of phenol (XII) with 1,1,1-trichloro-2-methyl-2-propanol (V) led to 2-phenoxyisobutyric acid (XIII), which was further esterified by treatment with SOCl2 in EtOH to yield (XIV). Friedel-Crafts acylation of (XIV) with bromoacetyl bromide (XV) in the presence of AlCl3 provided the phenacyl bromide (XVI). The corresponding phenethyl bromide (IX) was then obtained by reduction of ketone (XVI) with triethylsilane in trifluoroacetic acid.
【1】
Hirabayashi, A.; Tamai, T.; Muranaka, H.; Tanaka, N.; Ishikawa, T.; Mukaiyama, H.; Akahane, M.; Akahane, S.; beta(3)- Adrenoceptor agonists for the treatment of frequent urination and urinary incontinence: 2-[4-(2-[[1S,2R)-2- hydroxy-2-(4- hydroxyphenyl)-1-methylethyl]ethyl) phenoxy]-2-methylpropionic acid. Bioorg Med Chem 2001, 9, 12, 3265. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(V) |
25975 |
1,1,1-trichloro-2-methyl-2-propanol
|
57-15-8 |
C4H7Cl3O |
详情 | 详情
|
(IX) |
56067 |
ethyl 2-[4-(2-bromoethyl)phenoxy]-2-methylpropanoate
|
|
C14H19BrO3 |
详情 |
详情
|
(XII) |
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(XIII) |
56069 |
2-methyl-2-phenoxypropanoic acid
|
|
C10H12O3 |
详情 |
详情
|
(XIV) |
56070 |
ethyl 2-methyl-2-phenoxypropanoate
|
|
C12H16O3 |
详情 |
详情
|
(XV) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(XVI) |
56071 |
ethyl 2-[4-(2-bromoacetyl)phenoxy]-2-methylpropanoate
|
|
C14H17BrO4 |
详情 |
详情
|
合成路线24
该中间体在本合成路线中的序号:
(II) The acylation of N-[4-(4-aminophenyl)-2-thiazolyl]carbamic acid tert-butyl ester (I) with bromoacetyl bromide (II) gives the bromoacetamide (III), which is then condensed with (S)-alpha-methylbenzylamine (IV) to yield the glycinamide derivative (V). The acylation of (V) with 4-pyridylcarbonyl chloride affords the protected precursor (VI), which is finally deprotected to provide the target BILS 179 BS.
【1】
Crute, J.J.; et al.; Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease. Nat Med 2002, 8, 4, 386.
|
【2】
Hargrave, K.D.; Simoneau, B.; Faucher, A.-M.; Thavonekham, B.; Grygon, C.A.; Crute, J.J. (Boehringer Ingelheim (Canada) Ltd.; Boehringer Ingelheim Pharmaceuticals Inc.); Phenyl thiazole derivs. with anti-herpes virus properties. EP 0871619; JP 2000502702; US 6057451; WO 9724343 . |
【3】
Hargrave, K.D.; Simoneau, B.; Faucher, A.-M.; Crute, J.J.; Thavonekham, B.; Grygon, C. (Boehringer Ingelheim (Canada) Ltd.; Boehringer Ingelheim Pharmaceuticals Inc.); Antiherpes virus cpds. and methods for their preparation and use. US 6288091 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
54066 |
tert-butyl 4-(4-aminophenyl)-1,3-thiazol-2-ylcarbamate
|
n/a |
C14H17N3O2S |
详情 | 详情
|
(II) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(III) |
54067 |
tert-butyl 4-{4-[(2-bromoacetyl)amino]phenyl}-1,3-thiazol-2-ylcarbamate
|
n/a |
C16H18BrN3O3S |
详情 | 详情
|
(IV) |
20042 |
(1S)-1-phenyl-1-ethanamine; (1S)-1-phenylethylamine
|
|
C8H11N |
详情 |
详情
|
(V) |
54068 |
tert-butyl 4-{4-[(2-{[(1S)-1-phenylethyl]amino}acetyl)amino]phenyl}-1,3-thiazol-2-ylcarbamate
|
n/a |
C24H28N4O3S |
详情 | 详情
|
(VI) |
27850 |
isonicotinoyl chloride
|
39178-35-3 |
C6H4ClNO |
详情 | 详情
|
(VII) |
54069 |
tert-butyl 4-{4-[(2-{isonicotinoyl[(1S)-1-phenylethyl]amino}acetyl)amino]phenyl}-1,3-thiazol-2-ylcarbamate
|
n/a |
C30H31N5O4S |
详情 | 详情
|
合成路线25
该中间体在本合成路线中的序号:
(II) The acylation of N-[4-(4-aminophenyl)-2-thiazolyl]carbamic acid tert-butyl ester (I) with bromoacetyl bromide (II) gives the bromoacetamide (III), which is then condensed with 4-pyridylmethylamine (IV) to yield the glycinamide derivative (V). The acylation of (V) with cyclohexanecarbonyl chloride affords the protected precursor (VI), which is finally deprotected to provide the target BILS 103 BS.
【1】
Crute, J.J.; et al.; Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease. Nat Med 2002, 8, 4, 386.
|
【2】
Hargrave, K.D.; Simoneau, B.; Faucher, A.-M.; Thavonekham, B.; Grygon, C.A.; Crute, J.J. (Boehringer Ingelheim (Canada) Ltd.; Boehringer Ingelheim Pharmaceuticals Inc.); Phenyl thiazole derivs. with anti-herpes virus properties. EP 0871619; JP 2000502702; US 6057451; WO 9724343 . |
【3】
Hargrave, K.D.; Simoneau, B.; Faucher, A.-M.; Crute, J.J.; Thavonekham, B.; Grygon, C. (Boehringer Ingelheim (Canada) Ltd.; Boehringer Ingelheim Pharmaceuticals Inc.); Antiherpes virus cpds. and methods for their preparation and use. US 6288091 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
54066 |
tert-butyl 4-(4-aminophenyl)-1,3-thiazol-2-ylcarbamate
|
n/a |
C14H17N3O2S |
详情 | 详情
|
(II) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(III) |
54067 |
tert-butyl 4-{4-[(2-bromoacetyl)amino]phenyl}-1,3-thiazol-2-ylcarbamate
|
n/a |
C16H18BrN3O3S |
详情 | 详情
|
(IV) |
20042 |
(1S)-1-phenyl-1-ethanamine; (1S)-1-phenylethylamine
|
|
C8H11N |
详情 |
详情
|
(V) |
54068 |
tert-butyl 4-{4-[(2-{[(1S)-1-phenylethyl]amino}acetyl)amino]phenyl}-1,3-thiazol-2-ylcarbamate
|
n/a |
C24H28N4O3S |
详情 | 详情
|
(VI) |
17220 |
cyclohexanecarbonyl chloride; Cyclohexanecarboxylic acid chloride
|
2719-27-9 |
C7H11ClO |
详情 | 详情
|
(VII) |
54070 |
tert-butyl 4-[4-({2-[(cyclohexylcarbonyl)(4-pyridinylmethyl)amino]acetyl}amino)phenyl]-1,3-thiazol-2-ylcarbamate
|
n/a |
C29H35N5O4S |
详情 | 详情
|
合成路线26
该中间体在本合成路线中的序号:
(II) Acylation of the 2-aminobenzophenone (I) with bromoacetyl bromide (II) provides the bromoacetamide (III). Subsequent treatment of (III) with ammonia leads to the benzodiazepinone (IV). Methylation of the lactam N with iodomethane in the presence of K2CO3 gives rise to (V). The potassium enolate of benzodiazepinone (V) is then alkylated by 2-(bromomethyl)naphthalene (VI) to furnish the naphthylmethyl derivative (VII). Finally, methyl ether cleavage using AlBr3 in ethanethiol provides the target phenolic compound
【1】
Kim, K.; Volkman, S.K.; Ellman, J.A.; Synthesis of 3-substituted 1,4-benzodiazepin-2-ones. J Braz Chem Soc 1998, 9, 4, 375.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
63044 |
|
|
C14H12ClNO2 |
详情 |
详情
|
(II) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(III) |
63045 |
|
|
C16H13BrClNO3 |
详情 |
详情
|
(IV) |
63046 |
|
|
C16H13ClN2O2 |
详情 |
详情
|
(V) |
63043 |
|
|
C17H15ClN2O2 |
详情 |
详情
|
(VI) |
35612 |
2-(bromomethyl)naphthalene
|
939-26-4 |
C11H9Br |
详情 | 详情
|
(VII) |
63042 |
|
|
C28H23ClN2O2 |
详情 |
详情
|
合成路线27
该中间体在本合成路线中的序号:
(XII) Lithiationof 5-fluoro-2-methoxybenzoic acid (I) with sec-BuLi in the presence of TMEDA in THF, followed by methylation of the resulting anion with methyliodide, gives 3-fluoro-6-methoxy-2-methylben methyl benzoic acid (II). Chlorination of carboxylic acid (II) with (COCl)2 in the presence of DMF in CH2Cl2 and subsequent reaction of the resulting acid chloride with PhOH by means of Et3N and DMAP in CH2Cl2 provides the corresponding phenyl ester (III). O-Demethylation of ether (III) by means of BBr3 in CH2Cl2 at −78° Cyields the 6-hydroxybenzoate (IV),which is then protected with Boc2O and DMAP in CH2Cl2 to generate the tert-butyl carbonate (V). Treatment of compound (V) with LDA and TMEDA in THF at −78°C, followed by coupling with enone (VI) in THF, produces the tetraceno[2,3-d] isoxazole derivative (VII),which is subsequently deprotected with HF and TFA in acetonitrile to give the octa hydrotetracene derivative (VIII). Reductive cleavage of the isoxazolering of tetracycline (VIII) with H2 over Pd/Cin methanol/dioxane affords the 2-hydroxyamide (IX),which by nitration with HNO3 and H2SO4 affords the 9-nitro-tetracycline derivative (X). Reduction of the nitro group of compound(X) with H2 over Pd/Cin methanol/dioxane gives the corresponding amine(XI).Then, reaction of amine (XI) with bromoacetyl bromide(XII) in the presence of Na2CO3 in DMPU/acetonitrile provides the bromoacetamide(XIII), which is finally condensed with pyrrolidine(XIV). Alternatively,amine(XI) is directly condensed withp yrrolidin-1-ylacetyl chloride(XV) orits hydrochloride salt in DMF.
【1】
Zhou,J.,Xiao,X.-Y.,Plamondon,L.,Hunt,D.K.,Clark,R.B.,Zahler,R.B. (TetraphasePharmaceuticals, Inc.). CA2732883, CN102177134, EP 2323972,EP2682387, JP2011530534, KR2011058800, US2010105671, US2012302527, US2013109657, US8501716,WO 2010017470. |
【2】
Xiao,X.Y.,Hunt,D.K.,Zhou,J. etal.Fluorocyclines.1. 7-Fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: A potent, broad spectrum antibacterial agent. JMed Chem 2012, 55(2):597-605. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(III) |
67727 |
phenyl 3-fluoro-6-methoxy-2-methylbenzoate |
|
C15H13FO3 |
详情 | 详情
|
(V) |
67729 |
phenyl 6-((tert-butoxycarbonyl)oxy)-3-fluoro-2-methylbenzoate |
|
C19H19FO5 |
详情 | 详情
|
(I) |
67725 |
5-fluoro-2-methoxybenzoic acid;2-Methoxy-5-fluorobenzoic acid |
394-04-7 |
C8H7FO3 |
详情 | 详情
|
(II) |
67726 |
3-fluoro-6-methoxy-2-methylbenzoic acid |
|
C9H9FO3 |
详情 | 详情
|
(IV) |
67728 |
phenyl 3-fluoro-6-hydroxy-2-methylbenzoate |
|
C14H11FO3 |
详情 | 详情
|
(VI) |
67730 |
(4aR,8aR,9R)-3-(benzyloxy)-4a-((tert-
butyldimethylsilyl)oxy)-9-(dimethylamino)-8,8a,9,9a-
tetrahydronaphtho[2,3-d]isoxazole-4,5(3aH,4aH)-dione |
|
C26H34N2O5Si |
详情 | 详情
|
(VII) |
67731 |
(4aR,11aS,12aR,13R)-3-(benzyloxy)-4a-((tert-
butyldimethylsilyl)oxy)-13-(dimethylamino)-10-
fluoro-5-hydroxy-4,6-dioxo-
3a,4,4a,6,11,11a,12,12a,13,13a-decahydrotetraceno
[2,3-d]isoxazol-7-yl tert-butyl carbonate |
|
C39H47FN2O9Si |
详情 | 详情
|
(VIII) |
67732 |
(4aR,11aS,12aR,13R)-3-(benzyloxy)-13-
(dimethylamino)-10-fluoro-4a,5,7-trihydroxy-
11,11a,12,12a,13,13a-hexahydrotetraceno[2,3-d]
isoxazole-4,6(3aH,4aH)-dione |
|
C28H25FN2O7 |
详情 | 详情
|
(IX) |
67733 |
(4R,4aR,5aS,12aR)-4-(dimethylamino)-7-fluoro-
3,10,12,12a-tetrahydroxy-1,11-dioxo-
1,2,3,4,4a,5,5a,6,11,12a-decahydrotetracene-2-
carboxamide |
|
C21H23FN2O7 |
详情 | 详情
|
(X) |
67734 |
(4R,4aR,5aS,12aR)-4-(dimethylamino)-7-fluoro-3,10,12,12a-tetrahydroxy-9-nitro-1,11-dioxo-1,2,3,4,4a,5,5a,6,11,12a-decahydrotetracene-2-carboxamide |
|
C21H22FN3O9 |
详情 | 详情
|
(XI) |
67735 |
(4R,4aR,5aS,12aR)-9-amino-4-(dimethylamino)-7-fluoro-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,2,3,4,4a,5,5a,6,11,12a-decahydrotetracene-2-carboxamide |
|
C21H24FN3O7 |
详情 | 详情
|
(XII) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(XIII) |
67736 |
(4R,4aR,5aS,12aR)-9-(2-bromoacetamido)-4-(dimethylamino)-7-fluoro-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,2,3,4,4a,5,5a,6,11,12a-decahydrotetracene-2-carboxamide |
|
C23H25BrFN3O8 |
详情 | 详情
|
(XIV) |
11376 |
Pyrrolidine
|
123-75-1 |
C4H9N |
详情 | 详情
|
(XV) |
67737 |
2-(pyrrolidin-1-yl)acetyl chloride |
|
C6H10ClNO |
详情 | 详情
|
合成路线28
该中间体在本合成路线中的序号:
(I) Reaction of bromoacetyl bromide (I) with phenol at 80 °C gives the phenyl ester (II) , which by cyclization with (S)-(+)-phenylglycinol (III), previously treated with DIEA, in acetonitrile provides 5(S)-phenylmorpholin-2-one (IV) . Treatment of compound (IV) with HCl affords the corresponding HCl salt (V), which is reacted with NaHCO3 followed by coupling with benzodioxane-6-carboxaldehyde (VI) in refluxing EtOAc/toluene to yield the oxazine adduct (VII). Oxazine derivative (VII) can also be obtained by direct coupling of 5(S)-phenylmorpholin-2-one (IV) with aldehyde (VI) in refluxing toluene. Opening of adduct (VII) with pyrrolidine (VIII) in CH2Cl2, CHCl3 or refluxing THF followed by addition of HCl in refluxing MeOH leads to 3-(1,4-benzodioxan-6-yl)-3(R)-hydroxy-2(R)-(2-hydroxy-1-phenylethylamino)-1-(pyrrolidin-1-yl)propanone (IX), which is reduced with LiAlH4 in refluxing THF to give diol (X). Cleavage of diol (X) by means of H2 and Pd(OH)2 in the presence of either CF3COOH or HCl in MeOH or EtOH/H2O provides amine (XI), which is finally coupled with octanoic acid N-hydroxysuccinimide ester (XII) in CH2Cl2 . Ester (XII) is prepared by condensation of octanoyl chloride (XIII) with N-hydroxysuccinimide (XIV) by means of Et3N in CH2Cl2 .
【1】
Dellaria, J.F. Jr., Santarsiero, B.D. Enantioselective synthesis of alphaamino acid derivatives via the stereoselective alkylation of a homochiral glycine enolate synthon. J Org Chem 1989, 54(16): 3916-26. |
【2】
Siegel, C., Hirth, B.H. (Genzyme Corp.). Synthesis of UDP-glucose:N-acylsphingosine glucosyltransferase inhibitors. CA 2453978, EP 1409467, EP 2067775, JP 2005255686, JP 2005502635, JP 2010095546, US 2003050299, US 6855830, WO 2003008399. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(II) |
69187 |
phenyl 2-bromoacetate;Phenyl bromoacetate;alpha-Phenyl Bromoacetate;Phenyl a-bromoacetate;bromoacetic acidphenyl ester |
620-72-4 |
C8H7BrO2 |
详情 | 详情
|
(III) |
10973 |
(2S)-2-Amino-2-phenyl-1-ethanol; (S)-2-Hydroxy-1-phenylethylamine; (S)-(+)-2-Phenylglycinol; (S)-2-Amino-2-phenyl-1-ethanol
|
20989-17-7 |
C8H11NO |
详情 | 详情
|
(IV) |
61798 |
(5S)-5-phenyl-2-morpholinone;5(S)-phenylmorpholin-2-one;(5S)-3,4,5,6-Tetrahydro-5-phenyl-4(H)-1,4-oxazin-2-one |
144896-92-4 |
C10H11NO2 |
详情 | 详情
|
(V) |
69188 |
5(S)-phenylmorpholin-2-one hydrochloride |
|
C10H11NO2.HCl |
详情 | 详情
|
(VI) |
61797 |
2,3-dihydro-1,4-benzodioxine-6-carbaldehyde; 1,4-Benzodioxan-6-carboxaldehyde;
3,4-ethylenedioxybenzaldehyde
;benzodioxane-6-carboxaldehyde |
29668-44-8 |
C9H8O3 |
详情 | 详情
|
(VII) |
61799 |
(1S,3S,5S)-1,3-di(2,3-dihydro-1,4-benzodioxin-6-yl)-5-phenyltetrahydro-8H-[1,3]oxazolo[4,3-c][1,4]oxazin-8-one
|
|
C28H25NO7 |
详情 |
详情
|
(VIII) |
11376 |
Pyrrolidine
|
123-75-1 |
C4H9N |
详情 | 详情
|
(IX) |
61800 |
(2R,3R)-3-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-hydroxy-2-[(2-hydroxy-1-phenylethyl)amino]-1-(1-pyrrolidinyl)-1-propanone |
|
C23H28N2O5 |
详情 |
详情
|
(X) |
61801 |
(1R,2R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[(2-hydroxy-1-phenylethyl)amino]-3-(1-pyrrolidinyl)-1-propanol
|
|
C23H30N2O4 |
详情 |
详情
|
(XI) |
61802 |
(1R,2R)-2-amino-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(1-pyrrolidinyl)-1-propanol
|
|
C15H22N2O3 |
详情 |
详情
|
(XII) |
69189 |
octanoic acid N-hydroxysuccinimide ester;2,5-Dioxopyrrolidin-1-yl octanoate;Caprylic acid N-hydroxysuccinimide ester;N-(Octanoyloxy)succinimide;N-Hydroxysuccinimidyl caprylate |
14464-30-3 |
C12H19NO4 |
详情 | 详情
|
(XIII) |
11123 |
Octanoyl chloride; n-Caprylyl chloride;Capryloyl chloride |
111-64-8 |
C8H15ClO |
详情 | 详情
|
(XIV) |
10264 |
1-Hydroxydihydro-1H-pyrrole-2,5-dione; N-Hydroxysuccinimide; 1-Hydroxy-2,5-pyrrolidinedione
|
6066-82-6 |
C4H5NO3 |
详情 | 详情
|